QID 730344

Date Published: 2022-02-07

QID 730344: Dell Solutions Enabler Out-of-bounds Write Vulnerability

Solutions Enabler includes application programming interface (API) libraries that bridge software applications and the heterogeneous hardware and software infrastructure within a storage environment.

Affected Version:
Solutions Enabler and Solutions Enabler Virtual Appliance Versions prior to 9.1.0.16
Solutions Enabler and Solutions Enabler Virtual Appliance Versions prior to 9.2.1.2

QID Detection Logic:(Unauthenticated)
This QID sends a GET request to find if the target is running a vulnerable version of Solutions Enabler.

An unauthenticated remote attacker may potentially exploit this vulnerability to carry out a man-in-the-middle attack by supplying a crafted certificate and intercepting the victim's traffic to view or modify a victim's data in transit.

  • CVSS V3 rated as Critical - 8.8 severity.
  • CVSS V2 rated as High - 6.8 severity.
    • Solution
    Vendor has released fix to this vulnerability.

    Customers are advised to refer to DSA-2021-134 for more information.

    Vendor References

    CVEs related to QID 730344

    CVE-2021-21548 |
    Software Advisories
    Advisory ID Software Component Link
    DSA-2021-134 URL Logo www.dell.com/support/kbdoc/en-in/000189606/dsa-2021-134-dell-emc-unisphere-for-powermax-dell-emc-unisphere-for-powermax-virtual-appliance-dell-emc-solutions-enabler-virtual-appliance-and-dell-emc-powermax-embedded-management-security-update-for-multiple-third-party-component-vulnerabilities
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].